Pramiracetam

This classification denotes a neuroprotective agent with the molecular formula C14H27N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 4449F8I3LE, chemically known as 2,1,3-benzothiadiazole, 5-chloro-4-(2-imidazolin-2-ylamino)- but more generally known as pramiracetam, which bears US NIH Compound Identifier 5487. European Medicines Agency schedules Pramiracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09991MIG. The term PRAMIRACETAM is an International Non-Proprietary Name. World Health Organization schedules pramiracetam in its Anatomical Therapeutic Chemical (ATC) Classification. PRAMIRACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pramiracetam under HS 29337900 and SITC 51561. As of Q4 2014, PRAMIRACETAM remains US FDA's Preferred Term for this commodity. Pramiracetam bears US NLM identifiers UMLS ID C0071809 and NCI Concept Code C84171. SMILES: CLC1C(NC2=NCCN2)C2NSNC2CC1.